Advertisements

Finasterida Bluepharma

Quick links to important sections

Finasterida Bluepharma

Selected form

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Finasterida Bluepharma

Quick Facts

Property Description
Active ingredient Finasteride (INN)
Form Tablet (Oral, single-ingredient)
Pharmacological class 5-alpha Reductase Inhibitor (5-ARI)
General purpose Hormonal modulation of androgen-sensitive tissues
Origin Synthetic (4-azasteroid compound)
Manufacturer Bluepharma (Portuguese pharmaceutical group)

What Type of Medicine is Finasterida Bluepharma?

Finasterida Bluepharma is a prescription-only medication containing the active ingredient Finasteride, which is classified pharmacologically as a 5-alpha reductase inhibitor (5-ARI). This categorization establishes its function as an Androgen Antagonist that specifically targets hormonal pathways. The active ingredient is a synthetic 4-azasteroid compound administered as a single-ingredient, orally active tablet, designed for systemic absorption. A distinguishing factor of this medicine is its origin: it is produced by Bluepharma, a Portuguese pharmaceutical group recognized for its focus on developing and manufacturing generic finished dose products.

How Does Finasteride Generally Affect the Body?

The fundamental action of Finasteride involves a targeted hormone blockade achieved through the competitive inhibition of the Type II 5-alpha reductase enzyme. This enzymatic action is crucial because it significantly reduces the conversion of the less potent hormone, Testosterone, into the more powerful androgen, Dihydrotestosterone (DHT). This antiandrogenic effect is clinically recognized for its influence on conditions where tissue growth is dependent on DHT levels, such as in cases of prostate enlargement. The resulting DHT reduction is the core therapeutic basis, which generally influences the growth and stability of androgen-sensitive tissues by providing hormonal moderation.

Regulatory References

  1. NIH StatPearls
  2. MedlinePlus
  3. DHT reduction
Advertisements

What side effects are possible with Finasterida Bluepharma?

Finasterida Bluepharma’s safety profile, based on government regulatory documentation, includes adverse reactions categorized by frequency and the body system affected. The most frequently documented side effects are primarily associated with the reproductive system and psychiatric function.

Adverse Reaction Scope

Category Regulatory Summary
Common Side Effects Decreased libido, erectile dysfunction, and problems with ejaculation (e.g., reduced volume) are reported in up to 1 in 10 patients.
Uncommon Side Effects Breast tenderness and/or enlargement (gynecomastia), and skin rash are reported in up to 1 in 100 patients.
Serious Reactions (Not Known Frequency) Reports include male breast cancer and mood alterations such as depression and, rarely, suicidal ideation. Severe hypersensitivity reactions, including swelling of the face and throat (angioedema), are also noted.
Population Restrictions The medicine is contraindicated for use in women who are or may become pregnant due to the risk of external genital abnormalities in a male fetus. It is not indicated for use in children.

Safety Considerations and Restrictions

Adverse effects related to sexual function may appear early in the course of treatment; however, reports of persistent sexual dysfunction after discontinuing the medicine exist in post-marketing data. Finasteride reduces serum Prostate-Specific Antigen (PSA) levels by approximately 50%, a factor that must be considered when interpreting PSA values for prostate cancer screening, as stated in regulatory labels.

Connection to the overall safety profile:

The official safety profile is structured around the hormonal mechanism of action, with documented risks chiefly related to sexual function, breast tissue, and mood. The inclusion of absolute contraindications for pregnant women and mandatory guidance regarding the interpretation of PSA results defines the essential boundaries of this medicine's risk profile.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Finasteride (Finasterida Bluepharma) is characterized by a high threshold of systemic tolerance observed during clinical investigation. Information regarding overdose manifestations and required emergency actions is derived strictly from government-authorized prescribing documentation.

Documented Overdose Profile

Element Official Regulatory Finding
Observed Clinical Manifestations No adverse effects or reactions were observed following acute single doses up to 400 mg or multiple doses up to 80 mg/day for a duration of three months.
Physiological Systems Affected No specific physiological systems are explicitly documented as affected in the official overdose section, a finding consistent with the lack of adverse effects observed at high doses.
Specific Antidote No specific treatment for an overdose with Finasteride can be currently recommended until further clinical experience is obtained.

When to Seek Urgent Medical Help

While clinical studies documented no specific adverse signs in cases of high exposure, any suspected or confirmed ingestion of excessive amounts of medicine warrants immediate professional medical attention. This imperative action is consistent with the lack of a known specific antidote or defined management protocol in the official regulatory guidance. The official overdose statements reflect the drug’s observed high tolerability, defining the scope of emergency care needed.

Regulatory Classification Summary

The regulatory documentation does not assign a formal severity classification for overdose. The constraints of the overdose profile are defined by the observation that high-dose testing demonstrated clinical tolerability, and as a result, no specialized management procedures are detailed in the official government documents.

Advertisements

Therapeutic Uses of Finasterida Bluepharma

What Finasterida Bluepharma Treats: Main Uses and Benefits

Finasterida Bluepharma is a treatment that helps manage symptoms associated with two distinct male health conditions, contributing to symptomatic management. The therapeutic use of this medicine is grounded in established guidance.

Therapeutic Domains

This medication is considered relevant for the supportive management of Benign Prostatic Hyperplasia (BPH) and Male Pattern Hair Loss (Androgenetic Alopecia). It is generally used in situations involving certain distressing symptoms and applied across domains where additional symptomatic support is needed.

For BPH, it assists in addressing symptom clusters that may become intense or disruptive, such as difficulty initiating urination or a weak stream. For hair loss, it may assist with addressing visible symptoms and supporting maintenance of the hair's appearance, which supports general well-being during symptomatic phases.

The key therapeutic benefit is providing support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms.


Quick Facts on Usage

Quick Fact Therapeutic Domain
Assistance with Urinary Symptoms Applicable in conditions marked by heightened physiological stress related to BPH.
Support for Hair Appearance Used in contexts involving episodic or fluctuating symptom patterns related to hair loss.
Advertisements

Eligibility and Restrictions for Use

Finasterida Bluepharma is indicated for use exclusively in adult men and is not authorized for any other population. The official regulatory documents define strict non-eligibility rules based on gender, age, and pre-existing conditions.

Contraindicated Populations

The medicine is absolutely contraindicated and must not be used by the following groups:

  • Women/Females: Finasteride is not indicated for use in women for any condition.
  • Pregnancy: It is contraindicated in women who are or may potentially be pregnant due to the risk of fetal harm.
  • Hypersensitivity: Individuals with a known hypersensitivity to finasteride or any excipients in the tablet must not use this medicine.

Age and Condition-Specific Eligibility

Population Group Eligibility Status Special Consideration (If Any)
Pediatric Patients (< 18) Not Indicated Safety and efficacy have not been established.
Geriatric Patients Allowed No dosage adjustment is necessary.
Renal Impairment Allowed No dosage adjustment is necessary.
Hepatic Impairment Caution Use with caution, as the effect of liver function abnormalities has not been studied.

Women who are pregnant or may potentially be pregnant must not handle crushed or broken tablets, as the active ingredient can be absorbed through the skin, presenting a risk to a male fetus.

Advertisements

What should I know about interactions with other medicines?

Official Interaction Profile

The regulatory interaction profile for Finasterida Bluepharma is defined primarily by the finding that no drug interactions of clinical importance have been identified with a range of compounds tested in formal studies. These tested compounds include digoxin, propranolol, theophylline, and warfarin.

Metabolic and Exposure Risk

Finasteride is metabolized primarily by the Cytochrome P450 3A4 (CYP3A4) enzyme system. While Finasteride itself does not appear to significantly affect the metabolism of other medicines, it is probable that strong inhibitors or inducers of CYP3A4 will alter the plasma concentration of Finasteride. Based on established safety margins, however, any increase in exposure due to concomitant use of inhibitors is estimated to be unlikely to be of clinical significance.

Food and Herbal Cautions

There are no timing restrictions concerning meals; Finasteride can be taken with or without food. However, official government health guidance specifically notes a caution with the herbal remedy St John's wort, which might reduce the effectiveness of Finasteride.

Population-Specific Notes

The interaction profile includes a caution for patients with decreased hepatic function. As the drug undergoes extensive liver metabolism, Finasteride plasma levels may be increased in this population, though formal pharmacokinetic studies in hepatic insufficiency have not been conducted.

Advertisements

Mechanism of Action

Targeted Molecular Inhibition of Type II 5αR

The fundamental mechanism involves Finasteride acting as a competitive inhibitor of the Type II 5-alpha reductase (5αR) enzyme. This enzyme is the primary molecular target and is responsible for metabolizing the hormone Testosterone into the highly active androgen Dihydrotestosterone (DHT). By binding specifically and with high affinity to this enzyme isoform, the drug interferes with the conversion step.

Altering Androgen Metabolic Pathways

The sustained blockade of the 5αR enzyme causes a measurable and lasting reduction in the concentration of Dihydrotestosterone (DHT) throughout the body and within targeted tissues. This modulation of the Androgen Metabolic Pathway decreases the overall level of androgenic stimulation exerted by this metabolite, while Testosterone concentrations may exhibit a minimal, compensatory increase.

Physiological Modulation of Tissue Dynamics

The resulting decrease in DHT signaling at the cellular level reduces the androgenic stimulation of cell proliferation and maintenance in androgen-sensitive tissues. This cascade contributes to a change in the dynamics of cell growth in these specific organ systems. The final physiological effect is time-dependent, as it relies on the natural regression rate of the affected cells, rather than manifesting as an immediate physiological response.

Advertisements

Dosage and Administration Information

The medicine Finasterida Bluepharma is administered through the oral route as a film-coated tablet, following a non-variable, once-daily schedule. The dose is strictly defined by the condition being addressed. For the management of benign prostatic hyperplasia (BPH), the regimen is a 5 mg tablet taken once per day. For male pattern hair loss (androgenetic alopecia), the required dose is 1 mg taken once per day.

Administration is structured for consistent systemic delivery. The tablet may be taken with or without food, ensuring the fixed, once-daily frequency is maintained. It is a procedural requirement that the tablet must be swallowed whole and not be broken or crushed.

Finasteride is intended for continuous, long-term use. Daily treatment for several months (typically three to six months) is generally required before the full usage expectations can be determined. If a dose is missed, the user should skip that dose and resume the normal once-daily schedule, strictly avoiding a compensatory double dose. Furthermore, no dose adjustment is necessary for patients with reduced renal function.

Advertisements

Recent Clinical Evidence

Finasterida Bluepharma: Recent Clinical Evidence

Finasteride, the active compound in Finasterida Bluepharma, is classified as a 5-alpha reductase inhibitor. It is authorized for use in the management of two primary conditions: Androgenetic Alopecia (male pattern hair loss) at a lower dose (typically 1 mg), and Benign Prostatic Hyperplasia (BPH, enlarged prostate) at a higher dose (typically 5 mg).


Studies in Androgenetic Alopecia

Clinical data spanning over two decades support the use of finasteride in promoting hair growth and preventing further hair loss in men with androgenetic alopecia. Trials evaluated the effect of finasteride 1 mg/day versus placebo over observation periods up to five years.

  • Observed Effect: Studies showed a stabilization of hair loss in a majority of participants, with improvements in scalp hair counts reported when compared to the placebo group.
  • Mechanism Focus: Research confirms finasteride reduces the concentration of Dihydrotestosterone (DHT) in the scalp, the hormone centrally implicated in follicular miniaturization.

️ Evidence in Benign Prostatic Hyperplasia (BPH)

For BPH management, finasteride 5 mg is commonly evaluated in long-term studies, often lasting four years or more. Evidence focuses on the drug’s ability to reduce prostate volume and manage associated urinary symptoms.

Outcome Category Primary Study Findings
Prostate Volume Findings demonstrate a sustained reduction in prostate size
Urinary Flow Rate Trials report improvements in maximum urinary flow rate and reduced symptom scores

Finasteride is generally well-tolerated in clinical studies, but prescribers and patients should be aware of reported post-marketing data regarding potential sexual side effects.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Finasterida Bluepharma (FAQ)

Q: How quickly can someone expect to see any changes after starting Finasterida Bluepharma?

Finasteride begins to act in the body quickly by reducing the levels of the hormone Dihydrotestosterone (DHT). However, the therapeutic changes you may notice are time-dependent and require consistent use.

Official information indicates that several months of daily treatment, typically three to six months, are usually needed before the full expected effects of the medication become apparent for the condition being addressed.


Q: Can Finasterida Bluepharma be used for conditions other than prostate issues?

Finasteride is officially authorized for the management of two primary conditions in adult men. These are benign prostatic hyperplasia (BPH), which is prostate enlargement, and male pattern hair loss (androgenetic alopecia).

Regulatory documents list two primary authorized uses for Finasteride in adult men.


Q: If I stop taking Finasterida Bluepharma, will the effects go away?

Official information indicates that if treatment with Finasteride is stopped, the body’s levels of Dihydrotestosterone (DHT) will gradually return to their previous concentrations. As a result, the therapeutic benefits gained—such as reduced prostate size or stabilization of hair loss—are typically lost over time.


Q: Does Finasterida Bluepharma have to be taken at the exact same time every day?

Finasteride is administered as a fixed, once-daily schedule to maintain consistent levels in the body. Regulatory guidance emphasizes maintaining the consistent daily frequency.


Q: Can Finasterida Bluepharma be taken with supplements like saw palmetto or biotin?

Official drug interaction profiles specifically note a caution regarding the herbal remedy St John's wort, which may affect how well Finasteride works. The available regulatory documentation does not specifically list or provide guidance on interactions with other supplements like saw palmetto or biotin.


Q: Will taking Finasterida Bluepharma affect my ability to donate blood?

Official guidance from regulatory bodies and blood donation organizations often lists finasteride as a medication that may require a temporary deferral period for blood donation. This precaution is due to the potential risk of residual traces of the drug harming a pregnant female recipient.


Q: Does Finasterida Bluepharma affect fertility or sperm count?

Post-marketing surveillance has documented reports of male infertility and/or poor seminal quality in people using finasteride. These effects have typically been reported to resolve or improve after the medication was stopped.


Q: How long do doctors typically recommend a patient stay on Finasterida Bluepharma?

According to the official product information, Finasteride is intended for continuous, long-term use. The daily treatment regimen is required to maintain its therapeutic effects on the tissues it targets.


Q: What are the signs of a serious allergic reaction to Finasterida Bluepharma?

Regulatory documents report that severe hypersensitivity reactions have occurred in people taking finasteride. These reactions include angioedema, which is severe swelling of the face, lips, tongue, and throat.


Q: Is it normal to feel dizzy or lightheaded when taking Finasterida Bluepharma?

Dizziness and postural hypotension have been reported as side effects in clinical trials and post-marketing surveillance. Postural hypotension is a temporary drop in blood pressure that can cause lightheadedness or faintness when moving from sitting or lying down to standing.


Q: Can Finasterida Bluepharma be taken with common over-the-counter pain relievers?

Formal clinical studies have not identified any drug interactions of clinical importance with a wide range of tested compounds. However, the official drug interaction profile does not specifically name common non-prescription pain relievers (like ibuprofen or acetaminophen) in its list of tested compounds.


Q: What are the potential risks of taking Finasterida Bluepharma with blood thinners?

Clinical interaction studies specifically examined the co-administration of finasteride with warfarin, which is a common blood thinner. The studies found no drug interactions of clinical importance with warfarin.


Q: What is the purpose of the inactive ingredients in Finasterida Bluepharma tablets?

The inactive ingredients, also called excipients, are listed in the official product documents. These components do not have a therapeutic effect themselves but serve practical purposes, such as binding the tablet together, providing the film coating, or helping the medicine dissolve in the body.


Q: Do official sources mention any withdrawal symptoms when stopping Finasterida Bluepharma?

Official documentation notes that sexual adverse effects, such as decreased libido, may persist after a person stops taking the medicine. The term 'withdrawal symptoms' is not used in the regulatory documents to describe this persistence.


Q: What does the manufacturer say about the quality of Finasterida Bluepharma compared to the original drug?

As a generic medicine, Finasterida Bluepharma has been evaluated by regulatory authorities to ensure it is bioequivalent to the original reference product. This means it contains the same active ingredient and is required to meet the same standards for quality, strength, and efficacy.


Q: Does Finasterida Bluepharma require a special prescription or can any doctor prescribe it?

Finasterida Bluepharma is classified as a 'prescription-only medication' in major regulatory regions. This classification means that finasteride is only available via a prescription from a healthcare professional authorized to prescribe it.


Q: Why is patient information often focused on two different strengths of finasteride?

Official patient information focuses on two strengths because the active ingredient finasteride is authorized to treat two different conditions. The 5 mg dose is authorized for BPH, while the 1 mg dose is authorized for male pattern hair loss.


Q: What is the classification of Finasterida Bluepharma in terms of a controlled substance?

Regulatory drug registries do not classify Finasterida Bluepharma (finasteride) as a controlled substance in major regulatory regions like the United States or the United Kingdom.


Q: Can Finasterida Bluepharma affect my ability to drive or operate machinery?

Finasteride is not generally expected to impair the ability to drive or operate machinery. Regulatory guidance states that if a patient experiences side effects like dizziness or lightheadedness, they should be aware that these symptoms could potentially affect their ability to drive or operate machinery.


Q: Does Finasterida Bluepharma interact with herbal teas or natural remedies?

Official regulatory information specifically notes a caution regarding the herbal remedy St John's wort, which may affect the medicine’s effectiveness. There are no generalized warnings about all herbal teas or natural remedies.


Q: Why is follow-up blood work often suggested when taking Finasterida Bluepharma?

Follow-up blood tests are necessary because Finasteride reduces serum Prostate-Specific Antigen (PSA) levels by approximately 50%. This change must be carefully considered by a healthcare professional when interpreting the PSA results for prostate cancer screening.


Q: How does the drug work in the body at a basic level (beyond the 'How it works' section)?

Finasteride works by competitively inhibiting a specific enzyme called Type II 5-alpha reductase. This action prevents the conversion of the hormone testosterone into the more powerful androgen Dihydrotestosterone (DHT), thereby reducing the overall level of DHT in the body.


Q: What is the significance of the 'Bluepharma' name in the drug title?

The name 'Bluepharma' signifies the manufacturer of this medicine. Bluepharma is a pharmaceutical group based in Portugal that develops and produces finished dose products.


Q: Does Finasterida Bluepharma interact with cholesterol medications (statins)?

Official interaction studies have not identified a clinically significant interaction between finasteride and a wide range of tested compounds. However, cholesterol medications (statins) are not specifically named in the provided drug interaction profile.


Q: Can men of all ages use Finasterida Bluepharma?

The medicine is indicated for use exclusively in adult men and is not authorized for use in children. Regulatory information notes that geriatric patients are allowed to use the medicine, and no dosage adjustment is typically specified.


Q: Is a medical check-up required before starting Finasterida Bluepharma?

The Warnings and Precautions section in regulatory documents emphasizes the importance of an appropriate medical examination to rule out other serious conditions that may present with similar symptoms, especially before starting treatment for BPH.


Q: Does Finasterida Bluepharma affect blood pressure?

Although Finasteride is not a blood pressure medication, post-marketing reports have documented postural hypotension as a side effect. This refers to a temporary drop in blood pressure that can occur when a person quickly changes position, such as standing up.


Q: What is the difference between Finasterida Bluepharma and other finasteride brands?

Finasterida Bluepharma contains the same active ingredient, finasteride, and is regulated to meet the same standards for quality, strength, stability, and bioequivalence as other branded or generic finasteride products.


Q: Is Finasterida Bluepharma the same as the drug Proscar or Propecia?

Finasterida Bluepharma contains finasteride, which is the same active ingredient found in the branded drugs Proscar (typically 5 mg) and Propecia (typically 1 mg). Finasterida Bluepharma is a generic version of the medicine.


Q: Why do some people need to take a lower strength of Finasterida Bluepharma?

The difference in strengths is based on the specific condition that the medicine is authorized to treat. The lower 1 mg dose is authorized for male pattern hair loss, while the higher 5 mg dose is authorized for benign prostatic hyperplasia (BPH).


Q: Can I switch from a different brand of finasteride to Finasterida Bluepharma?

As Finasterida Bluepharma is a bioequivalent generic version of finasteride, it contains the identical active ingredient and meets the same quality and efficacy standards as other brands.


Q: Can Finasterida Bluepharma cause changes to my skin or hair texture?

Skin rash is listed as an uncommon side effect in official documents. There are no specific regulatory statements regarding changes to general hair or skin texture, outside of the therapeutic effect on scalp hair in male pattern hair loss.

Advertisements

How should Finasterida Bluepharma be stored and disposed of?

Storage and Stability

Finasterida Bluepharma tablets must be stored at room temperature, which is officially defined as not exceeding 30 C. To maintain stability, the medicine must be kept in its original packaging and protected from moisture. A crucial safety requirement is to keep the product out of the sight and reach of children.

Handling and Contact Precaution

Intact, film-coated tablets are safe for normal handling. However, women who are or may potentially be pregnant must not handle crushed or broken Finasterida tablets. This constraint is due to the potential for the active ingredient to be absorbed and subsequently pose a risk to a male fetus.

Disposal Instructions

Disposal must adhere to regulatory requirements to protect the environment. Unused, expired, or unwanted medicine must not be thrown away via wastewater or household waste. Instead, the medicine should be returned to a pharmacist for proper disposal in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Finasterida Bluepharma found in:

A-Z Index: